A study of diagnostic utility of serum ischemia modified albumin and IMA index in ischemic stroke and hemorrhagic stroke patients

Journal Title: Medpulse International Journal of Biochemistry - Year 2019, Vol 9, Issue 2

Abstract

Background: Stroke is associated with high morbidity and mortality rates, however, biochemical markers to aid in its early detection are lacking. As Ischemia Modified Albumin (IMA) is a novel marker for ischemia and previous studies have shown that its level increases acutely after ischemic stroke. Hence, it can be used to differentiate ischemic stroke from hemorrhagic and timely management of these patients. Objective: To compare levels of serum Ischemia Modified Albumin (IMA) in patients with ischemic and hemorrhagic stroke. Methods: Present cross sectional study comprised of 90 subjects, 30 ischemic stroke, 30 hemorrhagic stroke (definitive diagnosis based on radiological images) and 30 as apparently healthy control. Blood samples obtained within 24 hours of presentation were analysed for albumin by BCG dye binding method, IMA by albumin cobalt binding assay and albumin adjusted IMA index using formula by Lippi et al. Result: IMA concentrations were 0.340 ± 0.10 absorbance unit (ABSU) in control group, 0.45 ± 0.09ABSU in ischemic stroke and 0.38 ± 0.08ABSU in hemorrhagic stroke which were statistically higher (p< 0.0001) among stroke group as compared to control. There was also statistical significant difference (p< 0.003) of IMA concentrations between ischemic stroke and hemorrhagic stroke. A significant negative correlation between IMA and serum albumin (r = -0.75, p < 0.05) was observed. IMA index were 0.32±0.07 ABSU, 0.43±0.06 ABSU, 0.37±0.05 ABSU in control, ischemic and hemorrhagic stroke respectively and was highly significantly raised (p<0.0001) in ischemic stroke compared to hemorrhagic stroke and control. Conclusion: It is observed that IMA is a potential marker in diagnosing acute ischemia in cerebrovascular diseases as well as in differentiating types of stroke.

Authors and Affiliations

Sarika Argade, Reshakiran J Shendye

Keywords

Related Articles

Levels of folic acid, vitamin B12 and Malondialdehyde in stroke patients

Background: Stroke is a major health problem in elderly population, however there remains a significant subset of younger patients with ischemic stroke in whom conventional vascular risk factors play a smaller role. Foli...

Serodiagnosis of tuberculosis by indigenously developed antibody detection with Indirect ELISA

Background: India is the country with the highest burden of tuberculosis (TB). The World Health Organization (WHO) TB statistics for India for 2016 give an estimated incidence figure of 2.79 million cases of TB for India...

Protein bound hexose and protein bound hexosamine as diagnostic indicators in severe depression

Background: Depressive illness is considered to be a psychoneuro-immunological disorder due to peripheral immune activation through the release of pro inflammatory cytokines. Cytokines enhance the hepatic synthesis of gl...

25(OH) vitamin D level and severity of chronic liver disease: A controlled study from Eastern India

Background: Chronic Liver Disease (CLD) is defined as long term process of progressive degeneration and regeneration of liver cells and with advancement, leads to hepatic fibrosis, scarring, and cirrhosis. 25(OH) Vitamin...

Serum uric acid, serum iron levels in normal pregnancy and preeclampsia patients

Objective: Preeclampsia is pregnancy specific syndrome of reduced organ perfusion, secondary to vasospasm and endothelial activation associated with edema, BP: 140/90mm of Hg after 20 weeks of gestation and most frequent...

Download PDF file
  • EP ID EP521712
  • DOI 10.26611/1002926
  • Views 158
  • Downloads 0

How To Cite

Sarika Argade, Reshakiran J Shendye (2019). A study of diagnostic utility of serum ischemia modified albumin and IMA index in ischemic stroke and hemorrhagic stroke patients. Medpulse International Journal of Biochemistry, 9(2), 51-55. https://europub.co.uk/articles/-A-521712